Correction to: Fibroblast growth factor receptor 3 alterations and response to immune checkpoint inhibition in metastatic urothelial cancer: a real world experience.
Rose TL, Weir WH, Mayhew GM, Shibata Y, Eulitt P, Uronis JM, Zhou M, Nielsen M, Smith AB, Woods M, Hayward MC, Salazar AH, Milowsky MI, Wobker SE, McGinty K, Millburn MV, Eisner JR, Kim WY.
Rose TL, et al. Among authors: eisner jr.
Br J Cancer. 2022 May;126(8):1237. doi: 10.1038/s41416-022-01781-y.
Br J Cancer. 2022.
PMID: 35277660
Free PMC article.
No abstract available.